Synaffix Aims For Top ADC Tech Provider Spot After Inking MacroGenics Deal

Pact Potentially Worth $586m

 
• By Ayisha Sharma
  
Arrow hitting bullseye representing success.
Synaffix Hopes To Become Top Dog In Antibody Drug Conjugate Technology • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business